PIGK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.571400E-01
Normal-vs-Stage2
7.328400E-01
Normal-vs-Stage3
8.648000E-02
Normal-vs-Stage4
2.159000E-01
Stage1-vs-Stage2
4.556400E-01
Stage1-vs-Stage3
5.229900E-02
Stage1-vs-Stage4
2.508000E-01
Stage2-vs-Stage3
1.419250E-01
Stage2-vs-Stage4
6.994000E-02
Stage3-vs-Stage4
2.544300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.125400E-01
Normal-vs-AfricanAmerican
9.095200E-01
Normal-vs-Asian
4.807000E-01
Caucasian-vs-AfricanAmerican
7.295400E-01
Caucasian-vs-Asian
2.585800E-01
AfricanAmerican-vs-Asian
3.289200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.885600E-01
Normal-vs-Female
9.405800E-01
Male-vs-Female
1.950030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.648600E-01
Normal-vs-Age(41-60Yrs)
6.712000E-01
Normal-vs-Age(61-80Yrs)
7.488800E-01
Normal-vs-Age(81-100Yrs)
4.095600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.942400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.235200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.600400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.677900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.160300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.339200E-01
Normal-vs-Daily Drinker
4.920800E-01
Normal-vs-Weekly Drinker
4.625000E-01
Normal-vs-Occasional Drinker
6.050600E-01
Normal-vs-Social Drinker
8.630000E-01
Non Drinker-vs-Daily Drinker
7.064600E-01
Non Drinker-vs-Weekly Drinker
8.770000E-01
Non Drinker-vs-Occasional Drinker
3.514000E-02
Non Drinker-vs-Social Drinker
1.768770E-01
Daily Drinker-vs-Weekly Drinker
8.781800E-01
Daily Drinker-vs-Occasional Drinker
5.709800E-02
Daily Drinker-vs-Social Drinker
2.553400E-01
Weekly Drinker-vs-Occasional Drinker
5.572400E-02
Weekly Drinker-vs-Social Drinker
2.384600E-01
Occasional Drinker-vs-Social Drinker
5.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.414800E-01
Normal-vs-Grade 2
6.769800E-01
Normal-vs-Grade 3
3.292400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.598400E-01
Grade 1-vs-Grade 3
2.865800E-01
Grade 1-vs-Grade 4
4.414800E-01
Grade 2-vs-Grade 3
3.983400E-01
Grade 2-vs-Grade 4
6.769800E-01
Grade 3-vs-Grade 4
3.292400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.055800E-01
Normal-vs-NonDiabetic
8.484400E-01
Diabetic-vs-NonDiabetic
8.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.047600E-01
Normal-vs-NoPancreatitis
9.144800E-01
Pancreatitis-vs-NoPancreatitis
3.203700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.541600E-01
Normal-vs-N1
7.705000E-01
N0-vs-N1
3.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.912200E-01
Normal-vs-TP53-NonMutant
7.809600E-01
TP53-Mutant-vs-TP53-NonMutant
2.946800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
